Promises and pitfalls of intracellular delivery of proteins
- PMID: 25133522
- PMCID: PMC4166028
- DOI: 10.1021/bc500320j
Promises and pitfalls of intracellular delivery of proteins
Abstract
The direct delivery of functional proteins into the cell cytosol is a key issue for protein therapy, with many current strategies resulting in endosomal entrapment. Protein delivery to the cytosol is challenging due to the high molecular weight and the polarity of therapeutic proteins. Here we review strategies for the delivery of proteins into cells, including cell-penetrating peptides, virus-like particles, supercharged proteins, nanocarriers, polymers, and nanoparticle-stabilized nanocapsules. The advantages and disadvantages of these approaches including cytosolar delivery are compared and contrasted, with promising pathways forward identified.
Figures
References
-
- Shah D. A.; Kwon S. J.; Bale S. S.; Banerjee A.; Dordick J. S.; Kane R. S. (2011) Regulation of stem cell signaling by nanoparticle-mediated intracellular protein delivery. Biomaterials 32, 3210–3219. - PubMed
-
- Vasconcelos L.; Pärn K.; Langel U. (2013) Therapeutic potential of cell-penetrating peptides. Ther. Delivery 4, 573–591. - PubMed
-
- Kratz F.; Elsadek B. (2012) Clinical impact of serum proteins on drug delivery. J. Controlled Release 161, 429–445. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
